Published in Scand J Rheumatol on January 01, 2002
Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res (2006) 1.54
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease. Arthritis Res Ther (2012) 1.34
Expression of Th-17 and RORγt mRNA in Behçet's Disease. Med Sci Monit (2011) 1.13
Behçet's disease. Arthritis Res Ther (2003) 1.07
Biological treatments in Behçet's disease: beyond anti-TNF therapy. Mediators Inflamm (2014) 1.07
Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int (2007) 1.03
Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators Inflamm (2007) 1.02
Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease. Clin Exp Immunol (2005) 1.01
The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study. J Asthma Allergy (2012) 0.98
Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2009) 0.97
Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease. Clin Exp Immunol (2008) 0.97
Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease. Clin Med Res (2006) 0.94
Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease. J Immunol (2013) 0.91
Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis? Rheumatol Int (2005) 0.91
Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A. Mol Vis (2010) 0.90
Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations? Rheumatol Int (2005) 0.90
Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease. Rheumatol Int (2008) 0.90
Outcome measures used in clinical trials for Behçet syndrome: a systematic review. J Rheumatol (2014) 0.90
Proinflammatory cytokines and C-reactive protein in uveitis associated with Behçet's disease. Mediators Inflamm (2014) 0.89
IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population. Inflammation (2009) 0.89
Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells. J Immunol (2011) 0.88
T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet's disease. Clin Rheumatol (2007) 0.87
Current and future treatments for Behçet's uveitis: road to remission. Int Ophthalmol (2013) 0.85
Ex vivo effects of flavonoïds extracted from Artemisia herba alba on cytokines and nitric oxide production in Algerian patients with Adamantiades-Behçet's disease. J Inflamm (Lond) (2011) 0.83
Association Analysis of IL10, TNF-α, and IL23R-IL12RB2 SNPs with Behçet's Disease Risk in Western Algeria. Front Immunol (2013) 0.83
Immunopathogenesis of ocular Behçet's disease. J Immunol Res (2014) 0.83
Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease. Mediators Inflamm (2004) 0.81
Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol (2014) 0.81
Inflammation-related cytokine gene polymorphisms in Behçet's disease. J Inflamm Res (2015) 0.81
The role of cytokines in the pathomechanism of cutaneous disorders. Indian J Dermatol (2012) 0.81
Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet's disease with pulmonary involvement. Oxid Med Cell Longev (2010) 0.81
Transcriptional characteristics of CD4 T cells in young asthmatic children: RORC and FOXP3 axis. J Inflamm Res (2011) 0.81
Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease. Medicine (Baltimore) (2015) 0.81
Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease. Rheumatol Int (2004) 0.80
NOD2 is highly expressed in Behçet disease with pulmonary manifestations. J Inflamm (Lond) (2012) 0.80
Etanercept therapy in Behçet's disease. The tight control strategy in refractory disease. Z Rheumatol (2014) 0.79
Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens. Clin Exp Immunol (2016) 0.78
Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease. Arthritis Res Ther (2014) 0.78
Discrepant expression of cytokines in inflammation- and age-related cataract patients. PLoS One (2014) 0.78
Behçet syndrome: from pathogenesis to novel therapies. Clin Exp Med (2014) 0.77
Copy number variants and genetic polymorphisms in TBX21, GATA3, Rorc, Foxp3 and susceptibility to Behcet's disease and Vogt-Koyanagi-Harada syndrome. Sci Rep (2015) 0.77
High dose infliximab in the treatment of refractory uveitis: does dose matter? ISRN Rheumatol (2012) 0.77
Multiple Serum Cytokine Profiling to Identify Combinational Diagnostic Biomarkers in Attacks of Familial Mediterranean Fever. Medicine (Baltimore) (2016) 0.76
Serum IL-17A in Behçet's disease. Postepy Dermatol Alergol (2015) 0.76
Serum IL-33 level and IL-33 gene polymorphisms in Behçet's disease. Rheumatol Int (2014) 0.76
Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery. Mol Vis (2011) 0.76
Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells. Jpn J Ophthalmol (2011) 0.76
Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severity. J Extracell Vesicles (2017) 0.75
Salivary Interferon Gamma and Interleukin-4 Levels in Patients Suffering from Oral Lichen Planus. Cell J (2015) 0.75
Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease. Front Immunol (2017) 0.75
mRNA Expression Level of Interleukin Genes in the Determining Phases of Behçet's Disease. Ann Dermatol (2015) 0.75
Association between Polymorphism of Interleukin-23 Receptor and Hashimoto's Thyroiditis in Chinese Han Population of Shandong. Chin Med J (Engl) (2015) 0.75
Lack of association between IL10 polymorphisms and sarcoidosis in Japanese patients. Mol Vis (2012) 0.75
Analysis of Th Cell-related Cytokine Production in Behçet Disease Patients with Uveitis Before and After Infliximab Treatment. Ocul Immunol Inflamm (2016) 0.75
The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease. Medicine (Baltimore) (2016) 0.75
Circulating NK cells and their subsets in Behçet's disease. Clin Exp Immunol (2017) 0.75
Update on the Medical Management of Gastrointestinal Behçet's Disease. Mediators Inflamm (2017) 0.75
A Case of Myelodysplastic Syndrome with Intestinal Behçet's Disease-Like Symptoms Treated by Prednisolone and Azacitidine. Am J Case Rep (2015) 0.75
Expression of MicroRNAs in the Eyes of Lewis Rats with Experimental Autoimmune Anterior Uveitis. Mediators Inflamm (2015) 0.75
An autoinflammatory neurological disease due to interleukin 6 hypersecretion. J Neuroinflammation (2013) 0.75
The Role of Th17 Cells in the Pathogenesis of Behcet's Disease. J Clin Med (2017) 0.75
Neuro-Behçet disease mimicking brain tumor: A case report. Surg Neurol Int (2017) 0.75
Elevated insulin resistance in patients with recurrent aphthous stomatitis. Clin Oral Investig (2014) 0.75
Visfatin levels in Behcet's disease. Inflammation (2012) 0.75
A Study of Association Between Oral Lichen Planus and Immune Balance of Th1/Th2 Cells. Inflammation (2015) 0.75
Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody. Arthritis Res Ther (2017) 0.75
Associations between interleukin-1 polymorphisms and susceptibility to vasculitis: a meta-analysis. Z Rheumatol (2016) 0.75
Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood (2008) 2.12
Expression of Th-17 and RORγt mRNA in Behçet's Disease. Med Sci Monit (2011) 1.13
The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study. J Asthma Allergy (2012) 0.98
Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients--evidence of non-exosomal transport. Virol J (2013) 0.93
Vitamin D modulates peripheral immunity in patients with Behçet's disease. Clin Exp Rheumatol (2010) 0.91
Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population. Hum Immunol (2008) 0.89
Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review. Tunis Med (2007) 0.88
Association of vitamin D receptor gene polymorphisms with susceptibility to asthma in Tunisian children: A case control study. Hum Immunol (2012) 0.87
Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2009) 0.85
Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine (2008) 0.84
BAFF is up-regulated in central nervous system of neuro-Behçet's disease. J Neuroimmunol (2008) 0.83
Interleukin-18 gene polymorphisms in tunisian patients with inflammatory bowel disease. Digestion (2011) 0.83
Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD. World J Gastroenterol (2009) 0.82
Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Behçet's disease. J Neuroimmunol (2006) 0.81
Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II. Viral Immunol (2007) 0.81
Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease. Mediators Inflamm (2004) 0.81
Prognostic value of preoperative carcinoembryonic antigen level in colorectal cancer in Tunisia. Tunis Med (2012) 0.81
Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients. Viral Immunol (2013) 0.81
[Nasopharyngeal carcinoma in Tunisian children: retrospective epidemiological, clinical and biological study about 48 cases]. Bull Cancer (2005) 0.80
T cells expressing the gammadelta receptor are essential for Th2-mediated inflammation in patients with acute exacerbation of asthma. Mediators Inflamm (2002) 0.80
Cytokine and apoptosis gene polymorphisms influence the outcome of hepatitis C virus infection. Hepatobiliary Pancreat Dis Int (2011) 0.80
Regulatory T cells in cerebrospinal fluid from Behçet's disease with neurological manifestations. J Neuroimmunol (2007) 0.80
[IL1/IL1 Ra, CTLA-4 and Apo1/Fas genes polymorphisms and susceptibility to IgA nephropathy in Tunisian patients]. Tunis Med (2010) 0.79
Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection. Arab J Nephrol Transplant (2011) 0.79
Acute rejection episodes after kidney transplantation. Saudi J Kidney Dis Transpl (2009) 0.79
Role of genetic polymorphisms in factor H and MBL genes in Tunisian patients with immunoglobulin A nephropathy. Int J Nephrol Renovasc Dis (2010) 0.78
VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement. J Neuroimmunol (2009) 0.78
[Hepatitis C in kidney transplantation: comparative study between two Maghrebin centers: Casablanca and Tunis]. Tunis Med (2010) 0.78
Polymorphisms in oxidative stress-related genes are associated with nasopharyngeal carcinoma susceptibility. Immunobiology (2015) 0.78
CD86 +1057G>A polymorphism and susceptibility to acute kidney allograft rejection. Iran J Kidney Dis (2011) 0.77
Increased endothelin-1 levels of BAL fluid in patients with Behçet's disease. Mediators Inflamm (2007) 0.77
Association between CTLA-4 gene promoter (49 A/G) in exon 1 polymorphisms and inflammatory bowel disease in the Tunisian population. Saudi J Gastroenterol (2009) 0.77
[Importance of determination of C reactive protein (CRP), carcinoembryonic antigen (CEA) and lactic dehydrogenase (LDH) in colorectal cancer]. Tunis Med (2010) 0.77
Association of NAT2 gene substitution mutation T341C with increased risk for head and neck cancer in Tunisia. Acta Oncol (2007) 0.76
Use of common seric tumor markers in patients with solid cancers. Tunis Med (2008) 0.76
Anti-CCP antibodies, rheumatoid factors and anti-keratin antibodies: clinical value in established rheumatoid arthritis. Tunis Med (2011) 0.76
Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia. World J Gastroenterol (2010) 0.76
Atypical hemolytic uremic syndrome and mutation analysis of factor H gene in two Tunisian families. Int J Nephrol Renovasc Dis (2010) 0.76
[Bioclinical correlations in bony metastases. Results of a prospective study. 60 cases]. Tunis Med (2002) 0.75
[Diabetes following kidney transplantation. Report of 35 cases]. Tunis Med (2004) 0.75
[Impact of tobacco on bronchopulmonary affections: magnitude of the problem]. Tunis Med (2011) 0.75
[Seric soluble interleukin-2 receptor alpha in nasopharyngeal carcinoma in Tunisia. Prospective study about 45 cases]. Tunis Med (2007) 0.75
[Importance of biologic parameters in Helicobacter pylori gastritis: comparison with histological results]. Ann Biol Clin (Paris) (2010) 0.75
[Contribution of serum Cyfra 21-1 in nasopharyngeal carcinoma in Tunisia]. Bull Cancer (2004) 0.75
[Current etiologies of hemoptysis in the elderly: comparative study of 360 cases]. Tunis Med (2010) 0.75
[Changes in serum lipids in patients with colorectal cancer]. Tunis Med (2011) 0.75
Human platelet antigens polymorphisms and susceptibility of thrombosis in hemodialysis patients. Hemodial Int (2008) 0.75
[Pulmonary sequestrations: from radiologic to preoperative diagnosis: 2 cases with review of the literature]. Tunis Med (2006) 0.75
MDM2 344T>A polymorphism; could it be a predictive marker of anthracycline resistance? J BUON (2016) 0.75
Deletion polymorphism of glutathione S-transferases M1 and T1 in the Tunisian population. Tunis Med (2010) 0.75
Diagnostic value of the bronchoalveolar lavage in interstitial lung disease. Tunis Med (2016) 0.75
[A congenital deficiency of the C3 fraction of complement. A familial study]. Tunis Med (2003) 0.75
[Erythropoietin in cancer patients with anemia]. Tunis Med (2007) 0.75
[Vascular trombosis of renal graft: 9 cases]. Tunis Med (2008) 0.75
Childhood tuberculosis: A descriptive study in a pneumo-pediatrics department in Tunisia. Tunis Med (2016) 0.75
[Erythropoietin levels in perioperative period in cancer patients]. Bull Cancer (2007) 0.75
[Biological investigation of thyroid cancer]. Tunis Med (2006) 0.75
[The role of major histocompatibility complex genes in the pathogenesis of chronic inflammatory bowel diseases]. Tunis Med (2003) 0.75
[Immunological study in sickle cell disease patients: importance of the complement system]. Tunis Med (2003) 0.75
Hemophagocytic syndrome associated to a Hodgkin lymphoma. Tunis Med (2015) 0.75
[Hydatid cyst of the heart and vessels, four cases]. Presse Med (2005) 0.75
[Phenotypic and molecular changes of hemoglobinopathies in cancer]. Tunis Med (2013) 0.75
Hb H disease among Tunisians: molecular characterization of alpha-thalassemia determinants and hematological findings. Hemoglobin (2003) 0.75
[Skin allergy to hydrocortisone hemisuccinate in a patient with asthma]. Presse Med (2004) 0.75
[Cystic mature teratoma of the thymus]. Ann Pathol (2002) 0.75
A rare cause of fever associated with leukopenia in a renal transplant patient. Nephrol Dial Transplant (2004) 0.75